Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell

Life Sciences

Volumn 74, Issue 18, 2004, Pages 2251-2263

  Sakaida, Isao ^a   Hironaka, Koji ^a   Kimura, Teruaki ^a   Terai, Shuji ^a   Yamasaki, Takahiro ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrosis; Herbal medicine; Metalloproteinase; Signal transduction; Tissue inhibitor of metalloproteinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN TYPE 4; COLLAGENASE 3; GELATIN; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; PD 980597; SB 20238; SB 20380; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; XIAO CHAI HU TANG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; HERBAL MEDICINE; HOMEOSTASIS; LIVER CELL; MALE; MEDICINAL PLANT; NONHUMAN; NORTHERN BLOTTING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; STELLATE CELL; ZYMOGRAPHY;

RATTUS NORVEGICUS;

EID: 1342302807     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.059     Document Type: Article

References (44)

1. Araki N., Noda T., Ogawa K. Cytochemical studies on the effect of intraperitoneal and oral administration of a traditional Chinese medicine (Sho-saiko-to) on the D-galactosamine-induced hepatic injuries of rats. Acta Histochemia et Cytochemica. 21:1988;439-453.
2. Benyon R.C., Hovell C.J., Da Gaca M., Jones E.H., Iredale J.P., Arthur M.J. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology. 30:1999;977-986.
3. Boulton T.G., Nye S.H., Robins D.J., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675.
4. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biology. 7:1997;353-361.
5. Derijard B., Hibi M., Wu I.H., Barret T., Su B., Deng T., Karin M. JNK: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
6. Eberhardt W., Huwiler A., Beck K.F., Walpen S., Pfeilschifter J. Amplification of IL-1beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappaB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. Journal of Immunology. 165:2000;5788-5797.
7. Benbow U., Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biolology. 15:1997;519-526.
8. Chen A., Davis B.H. UV irradiation activates JNK and increases alphaI(I) collagen gene expression in rat hepatic stellate cells. Journal of Biological Chemistry. 274:1999;158-164.
9. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallangher T.F., Young P.R. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letter. 364:1995;229-233.
10. Dudley D.T., Pang L., Decker S.T., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proceedings of the National Academy of Science U.S.A. 92:1995;7686-7689.
11. Durko M., Navab R., Shibata H.R., Brodt P. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochimica et Biophysica Acta. 1356:1997;271-280.
12. Esparza J., Vilardell C., Calvo J., Juan M., Vives J., Urbano-Marquez A., Yague J. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood. 94:1999;2754-2766.
13. Friedman S.L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. New England Journal of Medicine. 328:1991;1828-1835.
14. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
15. Herron G.S., Banda M.J., Clark E.J., Gavrilovic J., Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. Journal of Biological Chemistry. 261:1986;2814-2818.
16. Hironaka K., Sakaida I., Matsumura Y., Kaino S., Miyamoto K., Okita K. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cells by gadolinium chrolide prevents pig serum-induced rat liver fibrosis. Biochemical and Biophysical Research Communications. 267:2000;290-295.
17. Iredale J.P., Benyon R.C., Arthur M.J., Ferris W.F., Alcolado R., Winwood P.J., Clark N. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
18. Kayano K., Sakaida I., Uchida K., Okita K. Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. Journal of Hepatology. 29:1998;642-649.
19. Kato M., Liu W., Yi H., Asai N., Hayakawa A., Kozaki K., Takahashi M., Nakashima I. The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice. Journal of Investigative Dermatology. 111:1998;640-644.
20. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmed M.F., Avruch J. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
21. Lee O.H., Bae S.K., Bae M.H., Lee Y.M., Moon E.J., Cha H.J., Kwon Y.G. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. British Journal of Cancer. 82:2000;385-391.
22. Li W.Q., Zafarullah M. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. Journal of Immunology. 161:1998;5000-5007.
23. Matsuzaki Y., Kurokawa F., Terai S., Matsumura Y., Kobayashi N., Okita K. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Japanese Journal of Cancer Research. 87:1996;170-177.
24. Merchant J.L., Du M., Todisco A. Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochemical and Biophysical Research Communications. 254:1999;454-461.
25. Oka H., Yamamoto S., Kanno T., Kuroki T., Mizoguchi Y., Kobayashi K. Controlled prospective evaluation of Sho-saiko-to in prevention of hepatocellular carcinoma in patients with cirrhosis of the liver. Cancer. 76:1995;743-749.
26. Okita K., Li Q., Murakami T., Takahashi M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. European Journal of Cancer Prevention. 2:1993;169-176.
27. Okita K., Kurokawa F., Yamasaki T., Furukawa T., Li Q., Murakami T. The use of Sho-saiko-to (TJ-9) for chemoprevention of chemical hepatocarcinogenesis in rats and discussion of its possible pharmacologic action. Transgenica. 1:1994;39-44.
28. Ravanti L., Hakkinen L., Larjava H., Saarialho-Kere U., Foschi M., Han J., Kahari V.M. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. Journal of Biological Chemistry. 274:1999;37292-37300.
29. Ravanti L., Heino J., Lopez-Otin C., Kahari V.M. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. Journal of Biological Chemistry. 274:1999;2446-2455.
30. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteianse expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
31. Sakaida I., Matsumura Y., Kubota M., Kayano K., Takenaka K., Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline deficient L-amino acid-defined diet. Hepatology. 23:1996;755-763.
32. Sakaida I., Matsumura Y., Akiyama S., Hayashi K., Ishige A., Okita K. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Journal of Hepatology. 28:1998;298-306.
33. Sakaida I., Hironaka K., Uchida K., Kayano K., Okita K. Fibrosis accelerates the development of enzyme-altered lesions in the rat liver. Hepatology. 28:1998;1247-1252.
34. Sakaida I., Uchida K., Hironaka K., Okita K. Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis. Journal of Gastroenterology. 34:1999;376-377.
35. Shimizu I., Ma Y.R., Mizobuchi Y., Liu F., Miura T., Nakai Y., Yasuda M., Amagaya S., Kawada N., Hori H., Ito S. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology. 29:1999;149-160.
36. Simon C., Goepfert H., Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Research. 58:1998;1135-1139.
37. Solis-Herruzo J.A., Rippe R.A., Schrum L.W., de La Torre P., Garcia I., Jeffrey J.J., Munoz-Yague T. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts. Journal of Biological Chemistry. 274:1999;30919-30926.
38. Tatsuta M., Ishii H., Baba M., Nakaizumi A., Uehara H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Japanese Journal of Cancer Research. 82:1991;987-992.
39. Trim J.E., Samra S.K., Arthur M.J., Wright M.C., McAulay M., Beri R., Mann D.A. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. Journal of Biological Chemistry. 275:2000;6657-6663.
40. Underwood D.C., Osborn R.R., Bochnowicz S., Webb E.F., Rieman D.J., Lee J.C., Romanic A.M. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. American Journal of Physiology-Lung Cellular and Molecular Physiology. 279:2000;L895-L902.
41. Wang M., Hu Y., Shima I., Stearns M.E. Identification of positive and negative regulator elements for the tissue inhibitor of metalloproteinase 1 gene. Oncology Research. 10:1998;219-233.
42. Yamamoto K., Araki N., Ogawa K. Ultrastructural and ultracytochemical examination of the effects of preadministration of Xia-Chai-Hu-Tang on hepatic disorders induced by D-galactosamine Hcl. Acta Histochemia et Cytochemica. 18:1985;403-418.
43. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Research. 54:1994;448-454.
44. Zeigler M.E., Chi Y., Schmidt T., Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. Journal of Cellular Physiology. 180:1999;271-284.